Effect of prosthetic titanium wear debris on mitogen-induced monocyte and lymphoid activation.
Wear debris generated by joint implant components has been reported to activate inflammatory and immune cells. Particulate debris derived from prosthetic material induces monocytes/macrophages, lymphocytes, synoviocytes, and fibroblasts to secrete cellular products, such as cytokines, which mediate inflammation. It has been speculated that degradation products impair the ability of inflammatory and immune cells to mount a protective response against noxious agents and infectious organisms by interfering with cell activation. Recent in vitro studies suggest that soluble metal ions inhibit T and B cell activation, but it is not known whether insoluble metal particles generated by prosthetic wear in tissue have the same effect. The purpose of the present study was to determine whether titanium wear debris retrieved from periprosthetic tissues surrounding a failed knee prosthesis suppresses activation of human monocytic and lymphoid cells. Peripheral blood monocytes and lymphocytes were incubated with the nonspecific activator pokeweed mitogen (PWM) in the presence or absence of titanium particles. Cell proliferative capacity and production of interleukins IL-1beta and IL-2 were determined as measures of activation. Titanium wear debris induced monocyte secretion of IL-1beta at levels comparable to those induced by PWM alone. In combination with PWM, titanium wear debris stimulated monocytes to secrete higher concentrations of IL-1beta than is stimulated by titanium itself or by PWM alone. Titanium wear debris did not activate lymphocytes, as indicated by marginal changes in DNA synthesis and IL-2 secretion, nor did it suppress the PWM-induced stimulation of DNA synthesis and IL-2 secretion. Our study suggests that nonspecific mitogen activators in spite of exposure to titanium wear debris can stimulate monocytic and lymphoid cells.
Kohilas
K
K
Johns Hopkins University, Department of Orthopaedic Surgery, The Good Samaritan Hospital, 5601 Loch Raven Blvd., Baltimore, Maryland 21239, USA.
Lyons
M
M
Lofthouse
R
R
Frondoza
C G
CG
Jinnah
R
R
Hungerford
D S
DS
D001672:Biocompatible Materials / Q000009:adverse effects* / Q000737:chemistry; D002455:Cell Division / Q000187:drug effects; D004247:DNA / Q000096:biosynthesis; D006801:Humans; D066298:In Vitro Techniques; D007375:Interleukin-1 / Q000378:metabolism; D007376:Interleukin-2 / Q000378:metabolism; D007720:Knee Prosthesis / Q000009:adverse effects*; D008213:Lymphocyte Activation / Q000187:drug effects; D008214:Lymphocytes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D008855:Microscopy, Electron, Scanning; D009000:Monocytes / Q000166:cytology / Q000187:drug effects* / Q000276:immunology; D010316:Particle Size; D011043:Pokeweed Mitogens / Q000494:pharmacology; D019904:Polymethyl Methacrylate / Q000009:adverse effects; D011137:Polystyrenes / Q000009:adverse effects; D011475:Prosthesis Failure; D013936:Thymidine / Q000378:metabolism; D014025:Titanium / Q000009:adverse effects* / Q000737:chemistry
D001672:Biocompatible Materials; D007375:Interleukin-1; D007376:Interleukin-2; D011043:Pokeweed Mitogens; D011137:Polystyrenes; D004247:DNA; D019904:Polymethyl Methacrylate; D014025:Titanium; D013936:Thymidine